SUMMARY Among a population of 75 hospitalised Parkinsonian subjects, confusional states were observed in 46% of demented patients not receiving anticholinergic drugs and in 93% of demented patients under anticholinergic therapy. The sensitivity of demented Parkinsonians to anticholinergic drugs can be attributed to a cholinergic deficiency which has been detected in the cortex and hippocampus of Parkinsonian patients post-mortem. The observations suggest that anticholinergic medication should be avoided in Parkinsonians with intellectual impairment.
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It has long been recognised that Parkinsonism is frequently accompanied by intellectual impairment. The incidence of dementia among Parkinsonians has been estimated to be about 30% on the basis of clinical'-6 and neuropathological evidence,7 although figures of over 50% have been advanced.8 9 It is not yet known, however, whether the dementing process is intrinsic to the pathology of the disease. On the assumption that lesions of the basal ganglia may be responsible for deficient intellectual performance as well as for the motor symptoms of the disease, the hypothesis was formed that Parkinsonians may suffer from a form of "subcortical dementia".'0 This notion has found echo among a number of authors. 13468 11-14 The neuronal system involved, however, have not been identified. The implication of cortical structures in Parkinsonian dementia is also suggested by observations of cortical atrophy'516 and neuropathological signs resembling those found in Alzheimer's disease and senile dementia in the brains of Parkinsonians.79 A recent biochemical study of Parkinsonian patients, performed post-mortem, has provided evidence as to nature of this lesion.'7 It was observed that choline acetyltransferase activity, measured as an index of cholinergic innervation, was significantly lower in the frontal cortex of Parkinsonians as compared to controls. This biochemical deficiency, ordinarily associated with senile and Alzheimer type dementia'821 was correlated in the Parkinsonian subjects studied with clinical observations of intellectual impairment, as far as this could be determined by retrospective analysis of the patients' records. An increase in muscarinic cholinergic receptors was also observed in the frontal cortex of these patients and was correlated with the decrease in choline acetyltransferase activity; the group of subjects that had received anticholinergic therapy had receptor densities greater than the mean for the group as a whole.
Since the muscarinic receptor antagonists used in the treatment of Parkinson's disease have been reported to produce confusional states, 222-24 we hypothesised that these episodes of confusion might be related to a pre-existing cholinergic deficit aggravated by receptor blockade. To confirm this hypothesis we attempted to determine clinically whether episodes of mental confusion corresponded to treatment with anticholinergic drugs and whether they were observed primarily in patients with impaired intellectual functions, that is with putative cholinergic deficits. To this end, the intellectual status, susceptibility to episodes of confusion, and treatment by anticholinergic drugs was determined for the 75 patients hospitalised during the year 1980 in the Neurology and Neuropsychology Clinic of the Salpetriere Hospital.
Patients and methods
All the Parkinsonian patients admitted to our unit during the year 1980 were hospitalised either to attempt to improve their motor condition or because of adverse reactions to treatment (on-off phenomena, dyskinesias, mental disturbances and/or intercurrent infections). The patients, all of whom were treated with Levodopa plus a peripheral decarboxylase inhibitor, were 1161 divided into four groups: non-demented patients without anticholinergic medication; non-demented patients with anticholinergic medication; patients suffering from intellectual deterioration (demented) without anticholinergic medication; demented patients with anticholinergic medication.
Dementia, defined as progressive and irreversible impairment of intellectual functions was assessed retrospectively on the basis of bedside evaluations of memory and higher intellectual functions, as noted in the patients' records and reported by family members. Mental confusion was considered to be an acute and reversible impairment of temporo-spatial orientation, inability to act or speak coherently with delirium in certain cases.
Although it is possible that the study is biased by the choice of a population of hospitalised Parkinsonians, the proportion of demented patients (36%) is the same as reported by other authors for a more general population of Parkinsonians and the incidence of confusion in non-demented patients (8%) falls within the reported range'2 (table 1). These 75 patients may therefore be tentatively considered as a representative population.
Results
Among the 75 patients, 27 (36%) had some degree of intellectual impairment and were considered to be demented ( Confusion, dementia and anticholinergics in Parkinson's disease confusion. Finally the disease was significantly more interest that the mesocortiocolimbic dopaminergic advanced in the demented subjects receiving system is affected in Parkinsonians.29 This lesion may anticholinergic therapy (group IV). While this factor is explain the symptoms of bradyphrenia in untreated not essential for the appearance of confusion in demented Parkinsonians,27 the improvement of some intellectual subjects, as evidenced by group III, it cannot be excluded functions as well as some of the psychic disturbances that this factor is involved in the increased incidence of observed after levodopa treatment30 5 and may indeed confusion among the patients of group IV. underlie the group of symptoms which Albert defined as "subcortical dementia". The other aspects of intellectual Discussion deterioration in Parkinsonians, which escape this definition may be related to the mesocortico-cortical We conclude that the presence of dementia in cholinergic lesion described here. Parkinsonians favours the appearance of confusional states and that the administration -of anticholinergic References medication to an intellectually impaired Parkinsonian will almost certainly result in mental confusion. 
